Complete Filing Data
Pyxis Oncology, Inc. reported Stockholders Equity of $53.41 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Pyxis Oncology, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$79.6M | -$77.3M | -$73.8M | -$120.7M | -$76.0M | -$12.8M |
| Research And Development Expense | $73.7M | $58.7M | $49.6M | $86.1M | $51.1M | $9.0M |
| Operating Income Loss | -$84.4M | -$89.5M | -$82.2M | -$123.5M | -$69.7M | -$12.9M |
| General And Administrative Expense | $22.2M | $25.4M | $32.6M | $37.4M | $18.7M | $3.8M |
| Nonoperating Income Expense | $6.2M | $10.0M | $8.4M | $2.8M | -$6.0M | $66.0K |
| Comprehensive Income Net Of Tax | -$79.7M | -$77.2M | -$73.7M | -$120.7M | ||
| Other Comprehensive Income Loss Net Of Tax | -$117.0K | $107.0K | $63.0K | |||
| Operating Expenses | $82.2M | $123.5M | $69.7M | $12.9M | ||
| Costs And Operating Expenses Total | $98.3M | $105.6M | $82.2M | |||
| Revenues | $13.9M | $16.1M | ||||
| Cost Of Revenue | $2.4M | $475.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$22.0M | -$18.4M | -$21.2M | -$21.2M | -$17.3M | -$3.3M | -$23.0M | -$15.9M | -$19.2M | -$27.7M | -$25.6M | -$31.4M | -$14.2M | -$8.1M | -$36.8M | -$3.2M | -$3.1M | -$2.0M |
| Research And Development Expense | $17.8M | $17.1M | $17.0M | $17.7M | $14.0M | $13.0M | $14.7M | $11.4M | $11.9M | $19.0M | $17.2M | $20.1M | $7.8M | $3.2M | $32.8M | $2.4M | ||
| Operating Income Loss | -$23.5M | -$19.8M | -$22.9M | -$23.8M | -$20.0M | -$5.6M | -$25.4M | -$18.1M | -$21.0M | -$28.4M | -$25.7M | -$31.4M | -$11.6M | -$5.9M | -$35.7M | -$3.2M | ||
| General And Administrative Expense | $5.7M | $5.4M | $5.9M | $6.0M | $6.1M | $8.2M | $10.7M | $6.7M | $9.1M | $9.4M | $8.6M | $11.3M | $3.8M | $2.7M | $3.0M | $767.0K | ||
| Nonoperating Income Expense | $1.5M | $1.7M | $1.8M | $2.6M | $2.7M | $2.3M | $2.3M | $2.2M | $1.7M | $719.0K | $164.0K | $9.0K | -$2.6M | -$2.0M | -$1.1M | $1.0K | ||
| Comprehensive Income Net Of Tax | -$21.9M | -$18.4M | -$21.3M | -$20.8M | -$17.3M | -$3.4M | -$23.1M | -$16.7M | -$18.5M | -$27.7M | -$25.6M | -$31.4M | ||||||
| Other Comprehensive Income Loss Net Of Tax | $74.0K | -$54.0K | -$121.0K | $453.0K | -$42.0K | -$123.0K | -$20.0K | -$781.0K | $696.0K | |||||||||
| Operating Expenses | $25.4M | $18.1M | $21.0M | $28.4M | $25.7M | $31.4M | $11.6M | $5.9M | $35.7M | $3.2M | ||||||||
| Costs And Operating Expenses Total | $23.5M | $22.6M | $22.9M | $23.8M | $20.0M | $21.8M | $25.4M | $18.1M | $21.0M | |||||||||
| Revenues | $2.8M | $16.1M | ||||||||||||||||
| Cost Of Revenue | $475.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $53.4M | $120.8M | $125.7M | $160.8M | $261.3M | -$15.6M | -$2.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $16.9M | $20.9M | $11.1M | $180.8M | $276.3M | $8.2M | $19.7M |
| Cash And Cash Equivalents At Carrying Value | $15.4M | $19.5M | $9.7M | $179.3M | $274.7M | $8.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$4.1M | $9.8M | -$169.6M | -$95.6M | $268.1M | -$11.5M | |
| Retained Earnings Accumulated Deficit | -$443.2M | -$363.6M | -$286.2M | -$212.4M | -$91.7M | -$15.7M | |
| Property Plant And Equipment Net | $8.0M | $9.9M | $11.9M | $11.2M | $1.0M | $1.1M | |
| Liabilities Current | $21.1M | $17.7M | $25.8M | $31.6M | $18.7M | $3.7M | |
| Liabilities And Stockholders Equity | $91.5M | $157.2M | $173.7M | $211.4M | $280.0M | $10.2M | |
| Liabilities | $38.1M | $36.4M | $48.0M | $50.6M | $18.7M | $3.9M | |
| Common Stock Value | $63.0K | $60.0K | $45.0K | $34.0K | $32.0K | $1.0K | |
| Assets Current | $72.1M | $132.4M | $124.6M | $186.6M | $278.7M | $8.1M | |
| Assets | $91.5M | $157.2M | $173.7M | $211.4M | $280.0M | $10.2M | |
| Accrued Liabilities Current | $8.6M | $11.4M | $13.0M | $24.5M | $6.6M | $2.0M | |
| Accounts Payable Current | $10.9M | $4.9M | $3.9M | $7.1M | $12.0M | $1.1M | |
| Operating Lease Right Of Use Asset | $11.4M | $12.2M | $12.9M | $13.6M | $232.0K | $836.0K | |
| Restricted Cash | $1.5M | $1.5M | $1.5M | $1.5M | $1.6M | $108.0K | |
| Operating Lease Liability Noncurrent | $17.0M | $18.7M | $20.1M | $18.9M | $165.0K | ||
| Operating Lease Expense | $824.0K | $700.0K | $660.0K | $1.1M | $604.0K | $365.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $16.9M | $20.9M | $11.1M | $180.8M | $276.3M | $8.2M | |
| Marketable Securities Unrealized Gain Loss | -$117.0K | $107.0K | $63.0K | ||||
| Restricted Cash Current | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | ||
| Operating Lease Liability Current | $1.7M | $1.5M | $1.2M | $165.0K | $615.0K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $53.0K | $170.0K | $63.0K | ||||
| Marketable Securities Current | $51.4M | $107.5M | $109.6M | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $3.0M | $6.1M | $4.8M | ||||
| Redemption Of Marketable Debt Securities | $165.9M | $168.5M | $92.0M | ||||
| Intangible Assets Net Excluding Goodwill | $0.00 | $2.6M | $24.3M | ||||
| Other Assets Noncurrent | $109.0K | $109.0K | |||||
| Issuance Of Common Stock Pursuant To At The Market Program Value Net Of Offering Costs | $12.2M | $6.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $68.8M | $87.6M | $103.1M | $153.7M | $169.8M | $184.2M | $137.9M | $145.3M | $152.2M | $188.7M | $212.0M | $233.5M | -$71.4M | -$57.6M | -$50.0M | -$11.1M | -$7.9M | -$4.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $10.4M | $12.2M | $14.2M | $13.5M | $26.5M | $29.4M | $16.2M | $27.4M | $54.5M | $200.0M | $224.8M | $248.7M | $133.6M | $142.6M | $140.8M | $11.4M | ||
| Cash And Cash Equivalents At Carrying Value | $8.9M | $10.7M | $12.8M | $12.1M | $25.1M | $28.0M | $14.7M | $25.9M | $53.1M | $198.5M | $223.4M | $247.1M | $133.5M | $142.5M | $140.7M | $11.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$6.7M | $18.3M | -$126.2M | -$27.6M | $132.6M | |||||||||||||
| Retained Earnings Accumulated Deficit | -$425.1M | -$403.1M | -$384.7M | -$328.0M | -$306.8M | -$289.5M | -$270.6M | -$247.6M | -$231.7M | -$176.3M | -$148.7M | -$123.1M | -$74.9M | |||||
| Property Plant And Equipment Net | $8.5M | $8.9M | $9.4M | $10.4M | $11.1M | $11.3M | $12.2M | $12.6M | $13.2M | $6.4M | $965.0K | $995.0K | $1.2M | |||||
| Liabilities Current | $19.4M | $17.7M | $14.4M | $20.3M | $16.9M | $14.1M | $28.3M | $9.2M | $11.6M | $19.1M | $14.9M | $19.2M | $16.8M | |||||
| Liabilities And Stockholders Equity | $105.6M | $123.2M | $135.9M | $195.3M | $208.4M | $220.2M | $186.7M | $175.2M | $182.8M | $223.9M | $242.6M | $252.7M | $139.5M | |||||
| Liabilities | $36.8M | $35.6M | $32.8M | $41.6M | $38.6M | $36.1M | $48.7M | $30.0M | $30.6M | $35.1M | $30.6M | $19.2M | $16.9M | |||||
| Common Stock Value | $62.0K | $62.0K | $62.0K | $59.0K | $59.0K | $59.0K | $44.0K | $39.0K | $37.0K | $32.0K | $32.0K | $32.0K | $2.0K | |||||
| Assets Current | $83.1M | $100.0M | $111.9M | $148.9M | $161.0M | $172.4M | $139.1M | $149.3M | $156.2M | $202.8M | $226.6M | $251.3M | $134.3M | |||||
| Assets | $105.6M | $123.2M | $135.9M | $195.3M | $208.4M | $220.2M | $186.7M | $175.2M | $182.8M | $223.9M | $242.6M | $252.7M | $139.5M | |||||
| Accrued Liabilities Current | $8.0M | $6.7M | $10.1M | $14.1M | $10.1M | $10.8M | $16.6M | $7.4M | $6.4M | $13.6M | $7.1M | $17.1M | $5.5M | |||||
| Accounts Payable Current | $9.8M | $9.4M | $2.8M | $4.9M | $5.5M | $2.3M | $3.3M | $1.3M | $4.0M | $5.5M | $7.8M | $2.1M | $1.9M | |||||
| Operating Lease Right Of Use Asset | $11.6M | $11.8M | $12.0M | $12.8M | $13.1M | $13.3M | $13.5M | $14.7M | $15.0M | $388.0K | ||||||||
| Restricted Cash | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.6M | $109.0K | $108.0K | $109.0K | $109.0K | ||
| Operating Lease Liability Noncurrent | $17.4M | $17.8M | $18.3M | $19.0M | $19.4M | $19.8M | $20.4M | $20.7M | $19.0M | $16.1M | $15.7M | |||||||
| Operating Lease Expense | $193.0K | $164.0K | $144.0K | $232.0K | $217.0K | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $10.4M | $12.2M | $14.2M | $13.5M | $26.5M | $29.4M | $16.2M | $27.4M | $54.5M | $200.0M | $224.8M | $248.7M | $133.6M | $142.6M | $140.8M | $11.4M | ||
| Marketable Securities Unrealized Gain Loss | $74.0K | -$54.0K | -$121.0K | $453.0K | -$42.0K | -$123.0K | -$20.0K | -$781.0K | $696.0K | |||||||||
| Restricted Cash Current | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | ||||||
| Operating Lease Liability Current | $1.6M | $1.6M | $1.5M | $1.4M | $1.0M | $1.2M | $527.0K | $1.2M | $325.0K | |||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $69.0K | -$5.0K | $49.0K | $351.0K | -$102.0K | -$60.0K | -$105.0K | -$85.0K | $696.0K | |||||||||
| Marketable Securities Current | $67.3M | $78.2M | $92.7M | $132.8M | $130.7M | $129.1M | $118.3M | $116.8M | $96.3M | |||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.2M | $1.3M | $607.0K | |||||||||||||||
| Redemption Of Marketable Debt Securities | $67.2M | $74.5M | ||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $2.4M | $2.5M | $2.5M | $23.6M | $23.7M | $23.7M | $22.3M | |||||||||||
| Other Assets Noncurrent | $449.0K | $109.0K | ||||||||||||||||
| Issuance Of Common Stock Pursuant To At The Market Program Value Net Of Offering Costs | $1.6M | $10.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $11.8M | $12.9M | $16.9M | $15.8M | $6.4M | $44.0K |
| Net Cash Provided By Used In Operating Activities | -$63.5M | -$57.7M | -$70.7M | -$89.3M | -$35.3M | -$10.1M |
| Net Cash Provided By Used In Investing Activities | $58.9M | $8.2M | -$104.8M | -$6.4M | -$590.0K | -$1.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$261.0K | $203.0K | -$2.5M | $3.4M | $2.4M | $13.0K |
| Increase Decrease In Operating Lease Liability | -$1.5M | -$1.2M | $2.4M | $4.3M | -$615.0K | -$421.0K |
| Increase Decrease In Accounts Payable | $6.0M | $1.2M | -$3.5M | -$8.3M | $4.6M | $558.0K |
| Payments To Acquire Property Plant And Equipment | $9.0K | $237.0K | $6.7M | $6.4M | $540.0K | $1.5M |
| Net Cash Provided By Used In Financing Activities | $594.0K | $59.3M | $5.9M | $183.0K | $304.0M | $35.0K |
| Proceeds From Stock Options Exercised | $632.0K | $296.0K | $120.0K | $183.0K | $167.0K | $32.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$2.8M | -$1.7M | -$14.1M | $12.0M | $5.1M | $1.7M |
| Depreciation Depletion And Amortization | $4.5M | $3.0M | $1.9M | $709.0K | $647.0K | $469.0K |
| Payments To Acquire Available For Sale Securities Debt | $107.0M | $160.1M | $196.8M | |||
| Increase Decrease In Contract With Customer Liability | -$7.7M | $998.0K | ||||
| Proceeds From Stock Issued Under Atm Net | $0.00 | $12.2M | $6.1M | |||
| Payments Related To Tax Withholding For Share Based Compensation | $148.0K | $240.0K | $445.0K | |||
| Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Private Placement | $2.0K | $46.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $3.6M | $4.3M | $4.9M | $3.4M | $2.5M |
| Net Cash Provided By Used In Operating Activities | -$22.5M | -$20.7M | -$26.8M | -$27.7M | -$18.7M |
| Net Cash Provided By Used In Investing Activities | $15.8M | -$18.5M | -$99.4M | -$146.0K | -$219.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $930.0K | $2.0M | -$486.0K | $232.0K | $71.0K |
| Increase Decrease In Operating Lease Liability | -$338.0K | -$552.0K | $1.3M | -$165.0K | -$146.0K |
| Increase Decrease In Accounts Payable | -$2.0M | -$1.4M | -$753.0K | -$9.9M | -$447.0K |
| Payments To Acquire Property Plant And Equipment | $237.0K | $4.4M | $146.0K | $169.0K | |
| Net Cash Provided By Used In Financing Activities | $57.5M | $176.0K | $151.5M | ||
| Proceeds From Stock Options Exercised | $245.0K | $176.0K | |||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.3M | -$2.1M | -$13.3M | $10.5M | -$491.0K |
| Depreciation Depletion And Amortization | $552.0K | $1.1M | $190.0K | $158.0K | $113.0K |
| Payments To Acquire Available For Sale Securities Debt | $51.4M | $92.8M | $95.0M | ||
| Increase Decrease In Contract With Customer Liability | -$7.7M | ||||
| Proceeds From Stock Issued Under Atm Net | $10.6M | ||||
| Payments Related To Tax Withholding For Share Based Compensation | $2.0K | $196.0K | |||
| Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Private Placement | $2.0K | $46.9M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.28 | -$1.32 | -$1.85 | -$3.65 | -$8.95 | -$12.45 |
| Weighted Average Number Of Shares Outstanding Basic | 62.1M | 58.4M | 39.9M | 33.0M | 8.5M | |
| Earnings Per Share Basic | $-1.28 | $-1.32 | $-1.85 | $-3.65 | $-8.95 | |
| Weighted Average Number Of Diluted Shares Outstanding | 62.1M | 58.4M | 39.9M | 33.0M | 8.5M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 190.0M | 190.0M | 190.0M | 190.0M | 190.0M | 40.3M |
| Common Stock Shares Outstanding | 62.7M | 60.0M | 44.8M | 35.0M | 32.2M | 1.3M |
| Common Stock Shares Issued | 62.7M | 60.0M | 44.8M | 35.1M | 32.8M | 2.2M |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Stock Value Shares Issued Net Of Tax Withholdings | -148.0K | -240.0K | -445.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.35 | -$0.30 | -$0.35 | -$0.35 | -$0.29 | -$0.06 | -$0.56 | -$0.41 | -$0.54 | -$0.85 | -$0.79 | -$0.97 | -$8.96 | -$5.54 | -$27.26 | -$2.93 |
| Weighted Average Number Of Shares Outstanding Basic | 62.6M | 61.9M | 61.0M | 60.7M | 60.5M | 51.3M | 41.3M | 38.4M | 35.4M | 32.6M | 32.5M | 32.3M | 1.6M | 1.5M | ||
| Earnings Per Share Basic | $-0.35 | $-0.30 | $-0.35 | $-0.35 | $-0.29 | $-0.06 | $-0.56 | $-0.41 | $-0.54 | $-0.85 | $-0.79 | $-0.97 | $-8.96 | $-5.54 | ||
| Weighted Average Number Of Diluted Shares Outstanding | 62.6M | 61.9M | 61.0M | 60.7M | 60.5M | 51.3M | 41.3M | 38.4M | 35.4M | 32.6M | 32.5M | 32.3M | 1.6M | 1.5M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Authorized | 190.0M | 190.0M | 190.0M | 190.0M | 190.0M | 190.0M | 190.0M | 190.0M | 190.0M | 190.0M | 190.0M | 190.0M | ||||
| Common Stock Shares Outstanding | 62.1M | 62.0M | 61.6M | 59.4M | 58.9M | 58.8M | 44.3M | 39.4M | 36.9M | 32.6M | 32.5M | 32.4M | 1.6M | |||
| Common Stock Shares Issued | 62.1M | 62.0M | 61.6M | 59.4M | 58.9M | 58.8M | 44.3M | 39.4M | 37.0M | 32.8M | 32.8M | 32.8M | 2.2M | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Restricted Stock Value Shares Issued Net Of Tax Withholdings | -8.0K | -67.0K | -2.0K | -1.0K | -43.0K | -196.0K | 2.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $11.8M | $12.9M | $16.9M | $15.8M | $6.4M | $44.0K |
| Stock Issued During Period Value Stock Options Exercised | $632.0K | $296.0K | $120.0K | $183.0K | $170.0K | |
| Additional Paid In Capital | $496.5M | $484.1M | $411.8M | $373.2M | $353.0M | $97.0K |
| Prepaid Expense Current | $3.8M | $4.0M | $3.8M | $5.8M | $2.5M | $23.0K |
| Investment Income Net | $3.6M | $7.0M | $6.6M | $2.8M | ||
| Sublease Income | $2.6M | $2.9M | $1.8M | |||
| Stock Issued During Period Value Restricted Stock Award Gross | -$445.0K | $3.0K | $10.0K | |||
| Stock Issued During Period Shares Stock Options Exercised | 345.4K | 123.3K | 83.2K | 73.8K | 70.4K | |
| Investment Income Interest | $2.8M | $23.0K | $66.0K | |||
| Capital Expenditures Incurred But Not Yet Paid | $237.0K | $4.5M | $11.0K | $28.0K | ||
| Stock Issued During Period Value Employee Stock Purchase Plan | $108.0K | $224.0K | $132.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.1M | $3.0M | $3.6M | $3.0M | $2.9M | $4.3M | $5.2M | $3.7M | $4.9M | $4.4M | $4.0M | $3.4M | $307.0K | $572.0K | $2.5M | $11.0K | $9.0K | $9.0K |
| Stock Issued During Period Value Stock Options Exercised | $48.0K | $245.0K | $117.0K | $3.0K | $6.0K | $1.0K | $176.0K | $3.0K | ||||||||||
| Additional Paid In Capital | $493.7M | $490.7M | $487.7M | $481.3M | $476.6M | $473.6M | $408.6M | $392.9M | $383.1M | $365.0M | $360.6M | $356.6M | $3.4M | |||||
| Prepaid Expense Current | $5.3M | $6.5M | $5.0M | $2.6M | $3.8M | $5.9M | $4.7M | $5.2M | $5.4M | $2.8M | $1.8M | $2.7M | $859.0K | |||||
| Investment Income Net | $774.0K | $995.0K | $1.2M | $1.8M | $2.0M | $1.6M | $1.7M | $1.7M | $1.7M | $719.0K | $164.0K | $9.0K | ||||||
| Sublease Income | $684.0K | $684.0K | $515.0K | $705.0K | $708.0K | $799.0K | $598.0K | $564.0K | $38.0K | |||||||||
| Stock Issued During Period Value Restricted Stock Award Gross | -$393.0K | $1.0K | $2.0K | $1.0K | $14.0K | $3.0K | $3.0K | $3.0K | $1.0K | $1.0K | ||||||||
| Stock Issued During Period Shares Stock Options Exercised | 101.0K | 0.00 | 51.1K | |||||||||||||||
| Investment Income Interest | $719.0K | $164.0K | $9.0K | $6.0K | $6.0K | $4.0K | $1.0K | |||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $2.3M | |||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $72.0K | $105.0K | $105.0K |
Most recent annual filing with the SEC: March 23, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.